150
Participants
Start Date
November 25, 2019
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Zephyr Valve Procedure
The Pulmonx Zephyr Endobronchial Valve is an implantable bronchial valve intended to decrease volume in targeted regions of the lung. It is indicated for the treatment of patients with severe emphysema. The Zephyr Valves are placed in the diseased region of the lung using bronchoscopy. As the diseased region of the lung shrinks in size, healthier regions may expand and function more efficiently, resulting in improved breathing.
University of Pittsburgh School of Medicine, Pittsburgh
The Lung Center, DuBois
University of Pennsylvania, Philadelphia
Temple University Hospital, Philadelphia
Inova Health, Fairfax
University of Alabama at Birmingham, Birmingham
Henry Ford Hospital, Detroit
Froedtert Memorial-Medical College of Wisconsin, Milwaukee
Northwestern Medicine, Winfield
University of Chicago, Chicago
Houston Methodist, Houston
Pulmonx Corporation
INDUSTRY